[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_95":96},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":16,"_18":19,"_20":-5,"_21":22,"_23":24,"_25":26,"_27":28,"_29":28,"_30":31,"_32":33,"_34":35,"_36":37,"_38":39,"_40":41,"_42":43,"_44":-5,"_45":46,"_47":-5,"_48":-5,"_49":50,"_51":52,"_53":54,"_55":56,"_57":56,"_58":59,"_60":39,"_61":62},"id","j0h1pd0inx2crqwlwyzvn2f0i","revision",2,"title","BioRestorative Therapies, Inc. (0001505497) (Filer)","originalTitle","summary","BioRestorative Therapies, Inc. 于2026年10月7日任命 Donald J. Currie 为董事，任期至2027年年度股东大会。Currie 将担任薪酬委员会和提名与公司治理委员会成员，并获得每月 2,000 加元的现金津贴。","reason","source",{"_11":85,"_86":87,"_88":89,"_90":56,"_91":92,"_93":94},"links",{"_82":83,"_62":84},"publishedAt","2026-10-09T20:05:40.000Z","discoveredAt","2026-10-09T20:21:29.178Z","timelineAt","category","paper","tags",[80,81],"stockSymbols",[79],"score",10,"selected",false,"channel","news","story",{"_71":72,"_15":73},"x","readingMode","full","author","language","body",{"_75":-5,"_62":76,"_77":-5,"_78":39},"outline",[],"relatedStories",[74],"indexable",true,"markdownAvailable","group",{"_63":64,"_42":65,"_66":67,"_68":69,"_70":69},"hasTranslation","bodyLanguage","original","factId","fMGLupF2CPr4",{"_71":72,"_15":73},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","f991b69f-d83f-480b-9f71-c1b7234919e7","BioRestorative Therapies 董事任命",{"_71":72,"_15":73},"zh","

UNITED\nSTATES

SECURITIES\nAND EXCHANGE COMMISSION

Washington,\nD.C. 20549

FORM\n8-K

CURRENT\nREPORT

Pursuant\nto Section 13 or 15(d) of the Securities Exchange Act of 1934

Date\nof Report (Date of earliest event reported): October\n7, 2026

BIORESTORATIVE\nTHERAPIES, INC.

(Exact\nname of registrant as specified in its charter)

\n \n \n \n \n \n \n \n \n \n \n \n \n

Nevada

001-37603

30-1341024

(State\n or other jurisdiction

of\n incorporation)

(Commission\n File Number)

(I.R.S.\n Employer

Identification\n No.)

40\nMarcus Drive

Melville,\nNew York 11747

(Address\nof principal executive offices) (Zip Code)

(631)\n760-8100

(Registrant’s\ntelephone number, including area code)

Not\napplicable

(Former\nname or former address, if changed since last report)

Check\nthe appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under\nany of the following provisions (see General Instruction A.2. below):

\n\n

☐

Written\ncommunications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

\n\n

☐

Soliciting\nmaterial pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

\n\n

☐

Pre-commencement\ncommunications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

\n\n

☐

Pre-commencement\ncommunications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities\nregistered pursuant to Section 12(b) of the Act:

\n \n \n \n \n \n \n \n \n \n \n \n \n

Title of each class		Trading Symbol(s)		Name of each exchange\n on which registered
Common Stock, par value $0.0001 per share		BRTX		Nasdaq Capital Market

Indicate\nby check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405\nof this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging\ngrowth company ☐

If\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item\n5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of\nCertain Officers.

Appointment\nof Donald J. Currie as Director

On October 7, 2026, the Board of Directors (the “Board”)\nof BioRestorative Therapies, Inc. (the “Company”) appointed Donald J. Currie as a Class I director of the Company,\neffective immediately, to fill the vacancy created by the previously reported resignation of Katharyn Field as a director effective August\n31, 2026. Mr. Currie will serve until the Company’s 2027 annual meeting of stockholders and until his successor is duly elected\nand qualified or his earlier death, resignation or removal. The Board also appointed Mr. Currie as a member of the Nominating and Corporate\nGovernance Committee and the Compensation Committee of the Board. Giving effect to Mr. Currie’s appointment, the standing committees\nof the Board are constituted as follows: Audit Committee: Steven Brown (Chair), Jatinder Dhaliwal, and Esha Randhawa; Compensation Committee:\nJatinder Dhaliwal (Chair), Steven Brown, Esha Randhawa and Donald J. Currie; and Nominating and Corporate Governance Committee: Esha Randhawa\n(Chair), Jatinder Dhaliwal, Steven Brown and Donald J. Currie.

The\nBoard has determined that Mr. Currie is an “independent director” under the listing rules of The Nasdaq Stock Market LLC,\nincluding the independence standards applicable to audit committee and compensation committee members, and under Rule 10A-3 under the\nSecurities Exchange Act of 1934, as amended (the “Exchange Act”).

Mr.\nCurrie, age 65, has served as Chief Executive Officer and a director of Hillcrest Energy Technologies Ltd. (CSE: HEAT; OTCQB: HLRTF),\na clean energy technology company engaged in the development of power conversion and digital control technologies for electric powertrains\nand grid-connected renewable energy systems, since February 2010. Mr. Currie has more than 30 years of experience in the energy sector\nand in the financing of public companies in the North American equity markets, and particular experience in the formation and management\nof companies, corporate strategy, team building and capital raising. Mr. Currie has not held any other position or employment, and has\nnot served as a director of any other company, during the past five years.

There\nis no arrangement or understanding between Mr. Currie and any other person pursuant to which he was appointed as a director. There are\nno family relationships between Mr. Currie and any director or executive officer of the Company, and there are no transactions between\nMr. Currie and the Company that would be reportable under Item 404(a) of Regulation S-K.

As\ncompensation for his service as a non-employee director and as a member of the committees of the Board, Mr. Currie will receive a cash\nfee of CAD $2,000 per month, payable monthly in arrears, and will be reimbursed for reasonable out-of-pocket expenses in accordance with\nthe Company’s policies applicable to non-employee directors. Mr. Currie will not participate in the Company’s standard non-employee\ndirector compensation program. The Company also expects to enter into an indemnification agreement with Mr. Currie in the form of indemnification\nagreement filed as Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on\nSeptember 2, 2026.

Item\n9.01 Financial Statements and Exhibits.

(d)\nExhibits.

\n \n \n \n \n \n \n \n \n

Exhibit No.		Description
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

	BIORESTORATIVE THERAPIES, INC.

	By:	/s/ Mika Grasso
	Name:	Mika Grasso
	Title:	Interim Chief Executive Officer

Date:\nOctober 9, 2026

","zhKind","complete","BRTX","宏观与美联储","财报","aihot","/items/j0h1pd0inx2crqwlwyzvn2f0i","https://www.sec.gov/Archives/edgar/data/1505497/000121390026108467/0001213900-26-108467-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1791763200&sig=95a77c187c5dca32","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1791763200&sig=3a0fa885471986b2 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1791763200&sig=31c65723824c6538 96w","changelogVersion","2026-10-01T08:00"]